Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.

Matthew Castelo Zachary BrownAngela E SchellenbergJane K MillsAndrea EisenDerek MuradaliEva GrunfeldAdena S Scheer

Published in: The breast journal (2021)

An MRI-based screening program for nonmutation carriers was effective at diagnosing breast cancer. However, this population experienced a high rate of abnormal screens and intervention. Further research is needed to improve the performance of MRI-based screening in these women.

Keyphrases

magnetic resonance imaging
contrast enhanced
quality improvement
high throughput
randomized controlled trial
genome wide
polycystic ovary syndrome
computed tomography
type diabetes
pregnant women
magnetic resonance
young adults
skeletal muscle
breast cancer risk